Naba Al Saha Medical Services Company (TADAWUL:9546)
Saudi Arabia
· Delayed Price · Currency is SAR 55.90
-3.20 (-5.41%)
At close: Dec 4, 2025
TADAWUL:9546 Income Statement
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 196.1 | 194.28 | 182.35 | 129.68 | 117.68 | 115.68 |
| Revenue Growth (YoY) | -0.35% | 6.54% | 40.61% | 10.20% | 1.73% | - |
| Cost of Revenue | 135.5 | 134.29 | 110.57 | 79.8 | 72.32 | 70.77 |
| Gross Profit | 60.6 | 60 | 71.78 | 49.88 | 45.36 | 44.92 |
| Selling, General & Admin | 33.17 | 32.05 | 27.94 | 19.32 | 17.54 | 17.35 |
| Operating Expenses | 35.84 | 34.73 | 27.94 | 20.07 | 17.54 | 17.35 |
| Operating Income | 24.76 | 25.27 | 43.84 | 29.81 | 27.82 | 27.57 |
| Interest Expense | -0.18 | -0.19 | -0.21 | -0.21 | -0.25 | -0.3 |
| Interest & Investment Income | 0.73 | 0.73 | 0.05 | - | - | - |
| Earnings From Equity Investments | -1.18 | -1.5 | -0.72 | -0.13 | - | - |
| Other Non Operating Income (Expenses) | 1.04 | 0.38 | 2.24 | -0.53 | -0.04 | 1.07 |
| EBT Excluding Unusual Items | 25.18 | 24.69 | 45.21 | 28.93 | 27.53 | 28.34 |
| Gain (Loss) on Sale of Investments | 0.28 | 0.37 | - | - | - | - |
| Asset Writedown | - | - | 2.33 | - | - | - |
| Other Unusual Items | - | - | 7.33 | - | - | - |
| Pretax Income | 25.46 | 25.06 | 54.86 | 28.93 | 27.53 | 28.34 |
| Income Tax Expense | 2.51 | 3.27 | 2.48 | 2.01 | 1.7 | 1.68 |
| Net Income | 22.95 | 21.78 | 52.38 | 26.92 | 25.83 | 26.65 |
| Net Income to Common | 22.95 | 21.78 | 52.38 | 26.92 | 25.83 | 26.65 |
| Net Income Growth | -39.06% | -58.41% | 94.57% | 4.24% | -3.10% | - |
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | - |
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | - |
| EPS (Basic) | 2.19 | 2.07 | 4.99 | 2.56 | 2.46 | - |
| EPS (Diluted) | 2.19 | 2.07 | 4.99 | 2.56 | 2.46 | - |
| EPS Growth | -39.06% | -58.41% | 94.57% | 4.24% | - | - |
| Free Cash Flow | -30 | -1.83 | -9.51 | 27.95 | 20.37 | -33.6 |
| Free Cash Flow Per Share | -2.86 | -0.17 | -0.91 | 2.66 | 1.94 | - |
| Dividend Per Share | 0.300 | 0.300 | - | 0.200 | 0.200 | - |
| Gross Margin | 30.90% | 30.88% | 39.36% | 38.46% | 38.55% | 38.83% |
| Operating Margin | 12.63% | 13.00% | 24.04% | 22.98% | 23.64% | 23.83% |
| Profit Margin | 11.70% | 11.21% | 28.73% | 20.76% | 21.95% | 23.04% |
| Free Cash Flow Margin | -15.30% | -0.94% | -5.21% | 21.55% | 17.31% | -29.05% |
| EBITDA | 33.94 | 34.36 | 51.53 | 35 | 32.47 | 32.18 |
| EBITDA Margin | 17.31% | 17.69% | 28.26% | 26.99% | 27.59% | 27.82% |
| D&A For EBITDA | 9.18 | 9.1 | 7.68 | 5.2 | 4.65 | 4.61 |
| EBIT | 24.76 | 25.27 | 43.84 | 29.81 | 27.82 | 27.57 |
| EBIT Margin | 12.63% | 13.00% | 24.04% | 22.98% | 23.64% | 23.83% |
| Effective Tax Rate | 9.86% | 13.06% | 4.52% | 6.95% | 6.18% | 5.94% |
Source: S&P Capital IQ. Standard template. Financial Sources.